| 周涛,陈柏楠,李昭辉.黄芪通脉汤治疗闭塞性动脉硬化的临床研究[J].中国中西医结合杂志,1997,(7):408-409 |
| 黄芪通脉汤治疗闭塞性动脉硬化的临床研究 |
| Clinical Study on Treatment of Arteriosclerosis Obliterans Using Huangqi Tongmai Decoction |
| 免费下载全文 查看/发表评论 下载PDF阅读器 |
| |
| DOI： |
| 中文关键词: 闭塞性动脉硬化 血脂 黄芪通脉汤 |
| 英文关键词:arteriosclerosis obliterans Huangqi Tongmai Decoction hyperlipidemia |
| 基金项目: |
|
| 摘要点击次数: 1359 |
| 全文下载次数: 982 |
| 中文摘要: |
| 目的：为观察和验证黄芪通脉汤对闭塞性动脉硬化（ＡＳＯ）患者血脂的调节作用。方法：选择ＡＳＯ患者３２例，应用黄芪通脉汤煎剂内服法治疗２个月，观察治疗前后血脂水平的变化。结果：治疗后患者血清高密度脂蛋白胆固醇升高、低密度脂蛋白胆固醇降低、动脉硬化指数下降（Ｐ＜０．０１）；血清胆固醇与甘油三酯、极低密度脂蛋白胆固醇、载脂蛋白（ａｐｏＡ１、ａｐｏＢ１００）均有变化（Ｐ均＜０．０５），ａｐｏＡ／ａｐｏＢ比值升高。结论：黄芪通脉汤具有明显的调脂作用。 |
| 英文摘要: |
| Objective:To test and verify the effects of Huangqi Tongmai Decoction (HQTMD) regulating blood lipid in treating arteriosclerosis obliterans (ASO). Methods:Thirty-two cases of ASO was treated with HQTMD for two months. The drug was in water decoction,oral taken.Results:Compared with the blood lipid level before treatment,the high density lipoprotein of cholesterol (HDL-C)was increased, the low density lipoprotein of cholesterol (LDL-C),atherogenic index (AI) was decreased (P<0.01). The serum total cholesterol (TC),triglyceride (TG),very low density lipoprotein of cholesterol (VLDL), apolipoprotein A1 (apoA1),apolipoprotein B100 (apoB100)were all changed (P<0.05). apoA1/apoB100. ratio increased. Conclusion: HQTMD could regulate blood lipid. This method was effective in treating ASO. |
| 关闭 |
|
|
|
扫描微信二维码，获取更多信息